Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra® in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders.
Saved in:
| Title: | Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra® in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders. |
|---|---|
| Authors: | Ferguson, DavidM. (AUTHOR), Hosmane, Balakrishna (AUTHOR), Heiman, JuliaR. (AUTHOR) |
| Source: | Journal of Sex & Marital Therapy. Jan/Feb2010, Vol. 36 Issue 1, p66-86. 21p. 2 Charts. |
| Subjects: | Orgasmic dysfunction, Drug efficacy, Blind experiment, Placebos, Randomized controlled trials, Drug side effects, Female orgasm |
| Abstract: | Over 256 women, age 21 to 65, with acquired mixed female sexual disorders participated in a 16-week randomized, placebo-controlled, double-blind study of Zestra®, a topical botanical preparation. Routine outcome instruments measured efficacy and safety. Zestra® was well tolerated. The only significant safety finding was mild-to-moderate genital burning seen only in Zestra®-treated subjects (14.6%). Zestra® provided significant desire, arousal, and treatment satisfaction benefits for a broadly generalized group of women with sexual difficulties. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Sex & Marital Therapy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Over 256 women, age 21 to 65, with acquired mixed female sexual disorders participated in a 16-week randomized, placebo-controlled, double-blind study of Zestra®, a topical botanical preparation. Routine outcome instruments measured efficacy and safety. Zestra® was well tolerated. The only significant safety finding was mild-to-moderate genital burning seen only in Zestra®-treated subjects (14.6%). Zestra® provided significant desire, arousal, and treatment satisfaction benefits for a broadly generalized group of women with sexual difficulties. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 0092623X |
| DOI: | 10.1080/00926230903375701 |
